COLUMBIA SPORTSWEAR v. SEIRUS INNOVATIVE ACCESSORIES -
Before Lourie, Moore, and Stoll. Appeal from the U.S. District Court for Southern District of California.
Summary: An accused infringer’s use of ornamental logos...more
Federal Circuit Summary -
Before Newman, Hughes, and Stoll. Appeal from the United States District Court for the District of Delaware
Summary: Objective indicia of nonobviousness cannot be dismissed merely because all...more
9/14/2018
/ Actavis Inc. ,
Appeals ,
Generic Drugs ,
Hatch-Waxman ,
Investigational New Drug Application (IND) ,
Nonobvious ,
Obviousness ,
Patent Infringement ,
Patent Invalidity ,
Patents ,
Pharmaceutical Patents ,
Remand ,
Reversal
Federal Circuit Summary -
Before Prost, Moore, and Reyna. Appeal from the United States District Court for the District of Massachusetts
Summary: A patent claim having multiple permutations is only enabled if each and...more
Federal Circuit Summaries -
Before Lourie, Dyk, and Hughes. Appeal from the United States District Court for the Central District of California
Summary: (1) The public use bar is not triggered by experimental use...more
7/13/2018
/ Appeals ,
Enhanced Damages ,
Experimental Use Exception ,
Jury Trial ,
Patent Infringement ,
Patent Litigation ,
Patent Validity ,
Patents ,
Public Use ,
Remand ,
Reversal ,
Willful Infringement
Federal Circuit Summaries -
Before Prost, Reyna, and Wallach. Appeal from the United States District Court for the Eastern District of Arkansas.
Summary: Pre-reexamination conduct cannot be a basis for equitable...more
Federal Circuit Summaries -
Before O’Malley, Plager and Taranto. Appeal from the U.S. District Court for the Northern District of California, Judge William H. Alsup.
Summary: Historical findings of fact relevant to...more
3/30/2018
/ Appeals ,
Copyright ,
Copyright Infringement ,
Damages ,
Fair Use ,
Google ,
JMOL ,
Jury Trial ,
Oracle ,
Oracle v Google ,
Remand ,
Reversal ,
Standard of Review ,
Transformative Use
The Federal Circuit held that a rat study in a provisional application and a conversion method in an uncited reference did not support the claimed human dosage form in Los Angeles Biomed. Research Inst. v. Eli Lilly & Co.,...more